CTRI/2012/07/002807已完成3 期
â??AN OPEN LABEL RANDOMISED CONTROLLED TRIAL OF PROBIOTICS FOR PRIMARY PROPHYLAXIS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSISâ??
G B Pant Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Cirrhotic patients, age 18-75 years.
- •No history of overt hepatic encephalopathy
排除标准
- •Patients on lactulose therapy
- •History of recent alcohol intake (in past 4 weeks)
- •Recent infection or antibiotic use (in past 6 weeks)
- •Patients on secondary prophylaxis for spontaneous bacterial peritonitis
- •Recent G I bleeding
- •Hepatocellular carcinoma
- •Previous TIPS and shunt surgeries
- •Use of psychotropic drugs which may affect psychometric tests
- •Any neurologic disease such as Alzheimerâ??s disease, Parkinsonâ??s disease and nonhepatic metabolic encephalopathies
- •Significant heart, respiratory or renal failure
研究者
相似试验
已完成
2 期
A clinical trial for validating therapeutic efficacy of convalescent plasma in severe COVID-19 diseaseCTRI/2020/05/025209Council of Scientific and Industrial Research80
已完成
2 期
EFFECT OF VSL#3 IN PATIENTS WITH MICROSCOPIC COLITISCTRI/2008/091/000086CD Pharma India Pvt Ltd30
招募中
2 期
Efficacy of Virechana followed by Gomutra-haritaki in the fatty liver disease?CTRI/2021/11/038277AD
已完成
不适用
.A.PER-025-99HOSPITAL NACIONAL DOS DE MAYO,
已完成
不适用
.A.PER-024-99IVERSIDAD PERUANA CAYETANO HEREDIA,